Treatment response, survival, safety, and predictive factors to chimeric antigen receptor T cell therapy in Chinese relapsed or refractory B cell acute lymphoblast leukemia patients

This study aimed to evaluate treatment response, survival, safety profiles, and predictive factors to chimeric antigen receptor T cell (CAR-T) therapy in Chinese patients with relapsed or refractory B cell acute lymphoblast leukemia (R/R B-ALL). 39R/R B-ALL patients who underwent CAR-T therapy were...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Limin, Liu, Jie, Xu, Mengyuan, Yu, Hongjuan, Lv, Chengfang, Cao, Fenglin, Wang, Zhenkun, Fu, Yueyue, Zhang, Mingwen, Meng, Hongbin, Zhang, Xiaoqian, Kang, Liqing, Zhang, Zhuo, Li, Jinmei, Feng, Jiawei, Lian, Xin, Yu, Lei, Zhou, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105502/
https://www.ncbi.nlm.nih.gov/pubmed/32231200
http://dx.doi.org/10.1038/s41419-020-2388-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105502/
https://www.ncbi.nlm.nih.gov/pubmed/32231200
http://dx.doi.org/10.1038/s41419-020-2388-1

Ejemplares similares